Saline infusion after clot-busting treatment for stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether giving extra normal (saltwater) fluid after standard clot-busting treatment improves recovery after a stroke. It could help reduce damage and improve outcomes for people who have had a moderate to severe stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must have had an acute ischemic stroke (a stroke caused by a blocked blood vessel) and received a clot-busting medicine (thrombolysis) within 4.5 hours of symptoms starting.
- Before this stroke, you should have been mostly independent (no significant disability).
- Your stroke symptoms must be moderate to moderately severe (a score of 4 to 25 on a standard stroke scale).
- You must not have significant heart problems like heart failure, atrial fibrillation, or heart valve disease.
- You must not have severe kidney problems (like high creatinine or low glomerular filtration rate).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special IV fluid with multiple electrolytes is better than normal saline (salt water) at preventing too much chloride in the blood for people who just had a bleeding stroke. If you need IV fluids after a recent brain bleed, this could help keep your blood chemistry balanced and improve recovery.
This trial tests a procedure called endovascular therapy (a way to remove the blood clot using a catheter) for people with a severe stroke caused by a large blockage in the back of the brain. The goal is to see if this treatment can improve outcomes compared to standard care.
This trial tests whether Cerebrolysin (a medication given through an IV) can help improve recovery after a stroke when given after a successful clot-removal procedure that happened several hours after the stroke began. It is being tested in people who had a large-vessel stroke in the front of the brain and meets certain imaging criteria. The goal is to see if the drug can reduce disability and improve recovery.
This trial tests if giving a clot-busting drug (tenecteplase) directly into the brain artery after a successful clot-removal procedure can improve outcomes for people with a major stroke. It is for patients who had a large vessel blockage and received endovascular thrombectomy within 24 hours of symptoms starting.
This trial tests whether giving a clot-busting drug to people with mild stroke symptoms (but no limb weakness) can improve recovery. It aims to see if this treatment is safe and helpful for this specific group.
This trial tests whether giving albumin, a protein naturally found in blood, can improve recovery after a large artery stroke when given along with a procedure to remove the clot. It's for people aged 18-80 who have a stroke from a blockage in the front part of the brain and can get treatment within 24 hours.
Hear when a new Brain Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.